These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report. Asou C; Sakamoto T; Suzuki K; Okuda I; Osaki A; Abe R; Ito Y; Kakegawa E; Miyakawa Y; Terui Y; Nakamura Y J Med Case Rep; 2024 Aug; 18(1):372. PubMed ID: 39154170 [TBL] [Abstract][Full Text] [Related]
5. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884 [TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals. Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335 [TBL] [Abstract][Full Text] [Related]
7. Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21). Abe A; Yamamoto Y; Katsumi A; Okamoto A; Tokuda M; Inaguma Y; Yamamoto K; Yanada M; Kanie T; Tomita A; Akatsuka Y; Okamoto M; Kameyama T; Mayeda A; Emi N Int J Hematol; 2018 Aug; 108(2):208-212. PubMed ID: 29264741 [TBL] [Abstract][Full Text] [Related]
8. Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid Leukemia. Gudipati M; Butler M; Koka R; Baer MR; Ning Y Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833323 [TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literature. Akhila Raj TV; Gopinath P; Geetha Raj JA; Narayanan G; Nair SG; Joy Philip DS; Raveendran S; Geetha P; Sreedharan H J Cancer Res Ther; 2022; 18(3):697-703. PubMed ID: 35900542 [TBL] [Abstract][Full Text] [Related]
10. Novel Four-Way t(8;14;15;21)(q22;q22;q15;q22.1) Translocation Variant in Acute Myeloid Leukemia with Tsuge N; Ogasawara F; Kondo T; Yoshida S; Kojima K Turk J Haematol; 2024 May; 41(2):128-129. PubMed ID: 38488305 [No Abstract] [Full Text] [Related]
11. Identification of a new translocation that disrupts the RUNX1 gene in a patient with de novo acute myeloid leukemia. Lucena-Araujo AR; de Figueiredo-Pontes LL; de Oliveira FM; de Lourdes Chauffaille M; Falcao RP; Rego EM Med Oncol; 2012 Jun; 29(2):1114-8. PubMed ID: 21380778 [TBL] [Abstract][Full Text] [Related]
12. t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia : A case report and literature review. Han B; Jing Y; Bi X; Lin Y; Li H; Li H; Ru K; Yang S Cancer Genet; 2024 Jun; 284-285():1-4. PubMed ID: 38460349 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Xie W; Wang SA; Yin CC; Xu J; Li S; Bueso-Ramos CE; Medeiros LJ; Tang G Exp Mol Pathol; 2019 Jun; 108():131-136. PubMed ID: 31004601 [TBL] [Abstract][Full Text] [Related]
15. t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymphoblastic leukemia [corrected]. Wang HY; Tirado CA Hum Pathol; 2010 Feb; 41(2):286-92. PubMed ID: 19896694 [TBL] [Abstract][Full Text] [Related]
17. AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR. XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780 [TBL] [Abstract][Full Text] [Related]
18. A new complex translocation t(8;11;21)(q22;q24;q22) in acute myeloid leukemia with RUNX1/RUNX1T1. Yamamoto K; Yakushijin K; Funakoshi Y; Sanada Y; Kawamoto S; Matsuoka H; Minami H J Clin Exp Hematop; 2014; 54(2):167-70. PubMed ID: 25318951 [No Abstract] [Full Text] [Related]
19. An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1. Al-Harbi S; Aljurf M; Mohty M; Almohareb F; Ahmed SOA Blood Adv; 2020 Jan; 4(1):229-238. PubMed ID: 31935293 [TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic investigations in a novel complex variant of t(8;21)(q22;q22) with ins(15;21)(q15;q22.2q22.3) in a patient with AML-M2 subtype. Kokate P; Ahmad F; Dalvi R; Das BR; Mandava S Cancer Genet Cytogenet; 2008 Jul; 184(1):52-6. PubMed ID: 18558290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]